Karol Pawel Budohoski

Karol Budohoski practices at University of Utah Hospitals and Clinics - Unit in Salt Lake City, Utah.

Karol Budohoski's NPI, 1679162408, was assigned on January 15, 2021. Karol Budohoski graduated from Medical University of Warsaw in 2008. Karol Budohoski holds California license F665.

Karol Budohoski's primary practice is University of Utah Hospitals and Clinics - Unit, at 50 North Medical Drive, Salt Lake City, UT 84132 in Salt Lake County. The practice phone is (801) 581-2337.

Karol Budohoski's primary practice is University of Utah Hospitals and Clinics - Unit in Salt Lake City, Utah. Karol Budohoski is also affiliated with University of Utah Hospital. The medical group on file is Portneuf Medical Center - Pediatric Cardiology. Dmand AI also links Karol Budohoski to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Karol Budohoski practices, 7 sites in all. Vendor and product names are available with a free account.

Neurological surgery is Karol Budohoski's primary specialty in the NPI Registry, under taxonomy code 207T00000X. Dmand AI has Karol Budohoski's licenses on file in 3 states: California, Montana and Utah.

Dmand AI lists craniotomy among the conditions Karol Budohoski treats.

CMS data shows 378 Medicare services from Karol Budohoski across 14 procedure codes in 2024, for 132 Medicare patients. Medicare paid $49,449 for them.

CMS counts 132 Medicare patients who saw Karol Budohoski in 2024. The largest group is 65 to 74, with 68 patients. 75% of them have high blood pressure, and 67% have high cholesterol. 17% are also on Medicaid. Their average risk score is 1.39, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Karol Budohoski's median patient age at 71, with 58% women.

In 2024, Karol Budohoski wrote 90 Medicare Part D claims for 32 patients. 91% of them were for generic drugs. CMS names the drug for 50 of them, across 2 drugs with 11 or more claims each, at $4,717 in total drug cost. In 2023, CMS named 51 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Karol Budohoski for performance year 2024, reported as part of a group. Karol Budohoski accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Karol Budohoski as offering telehealth.

Dmand AI links 92 papers to Karol Budohoski, published from 2012 to 2025. 2022 was the busiest year, with 18. The most frequent topics are Neurosurgical Procedures, Subarachnoid Hemorrhage and Cerebrovascular Circulation. Karol Budohoski has published most often in World Neurosurg. Karol Budohoski's most frequent co-authors are William Tupper Couldwell, MD, Robert C. Rennert, MD and Michael T. Bounajem, MD.

CMS Open Payments shows 64 general payments to Karol Budohoski from 12 drug and device companies from 2021 to 2025. Charitable contributions make up the largest share, 55% of the total. Mizuho America, Inc. paid the most, $16,155.

Karol Budohoski graduated from Medical University of Warsaw in 2008.

Karol Budohoski is in network with 18 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.